Clinicopathological Correlation in Perimenopausal Women With Abnormal Uterine Bleeding Undergoing Endometrial Sampling
Main Article Content
Abstract
Background: Abnormal uterine bleeding is a common gynecological presentation during perimenopause and may reflect benign hormonal changes, structural uterine lesions, endometrial hyperplasia, or malignancy. Because clinical symptoms and ultrasound findings may overlap across benign and high-risk pathology, histopathological assessment remains important for accurate diagnosis. Objective: To evaluate clinical presentation, transvaginal ultrasound findings, and histopathological patterns among perimenopausal women with abnormal uterine bleeding undergoing endometrial sampling. Methods: This descriptive cross-sectional study included 350 perimenopausal women aged 40–55 years presenting with abnormal uterine bleeding at tertiary-care hospitals in Lahore, Pakistan. Demographic and clinical data were recorded, transvaginal ultrasound was performed to assess endometrial thickness and focal lesions, and endometrial sampling was conducted using Pipelle biopsy or hysteroscopic-guided sampling when indicated. Data were analyzed using descriptive statistics and association testing. Results: The mean age was 47.8 ± 4.2 years and mean body mass index was 28.3 ± 5.1 kg/m². Heavy menstrual bleeding was the most common presentation (55.1%), followed by intermenstrual bleeding (25.1%). Endometrial thickening of ≥5 mm was present in 40.0%, and focal lesions were identified in 25.0%. Benign histopathological findings accounted for 79.7%, hyperplasia without atypia for 6.0%, atypical hyperplasia for 9.1%, and carcinoma for 5.1%. High-risk pathology was present in 14.3%. Conclusion: Most perimenopausal women with abnormal uterine bleeding had benign pathology, but a clinically important minority had atypical hyperplasia or carcinoma. Integrated clinical, ultrasound, and histopathological assessment is essential for timely diagnosis and risk stratification.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Vitale SG, Vitale MG, Campo S, et al. Abnormal uterine bleeding in perimenopausal women. Climacteric. 2022;25(1):S1-S10. doi:10.1016/j.maturitas.2024.107944.
2. Nair BL, Kuriakose LS. Histopathological evaluation of endometrial sampling in perimenopausal women with abnormal uterine bleeding. Int J Reprod Contracept Obstet Gynecol. 2021;10(8):3180-3185. doi:10.18203/2320-1770.ijrcog20212977.
3. Chapagain S, Dangal G. Clinical and histopathological presentation of abnormal uterine bleeding in perimenopausal women. J Nepal Health Res Counc. 2020;18:248-252. doi:10.33314/jnhrc.v18i2.2512.
4. Khanzada B, Rehman T, Mansoor S. Hyperplasia of endometrium in perimenopausal women with abnormal uterine bleeding. Pak Armed Forces Med J. 2020;67 Suppl 1:S1-S5. doi:10.18203/2320-1770.ijrcog20200380.
5. Alia A, Umer S, Yasin S, et al. High variability in clinical and histopathological patterns of abnormal uterine bleeding in perimenopausal women. Pak J Med Health Sci. 2022;16(11):331-335. doi:10.53350/pjmhs20221611331.
6. Mirza GF, Hayat Z, Nazeer S. Frequency of structural and hormonal causes of abnormal uterine bleeding in perimenopausal women. JSOGP. 2025;15(4):964. doi:10.71104/jsogp.v15i4.964.
7. Husna UHZ, et al. Prevalence and clinical patterns of abnormal uterine bleeding in perimenopausal women. TAJ J Teachers Assoc. 2025;38(02):0592. doi:10.70818/taj.v38i02.0592.
8. Raj E, Ibrahim MI, Ahmed S, et al. Sonographic and histopathological correlation and evaluation of endometrium in perimenopausal women with abnormal uterine bleeding. Pak J Med Dent. 2025;14(4):070. doi:10.36283/ziun-pjmd14-4/070.
9. Vichitra S, Kudva R. Histopathological profile of endometrium among peri- and postmenopausal women with abnormal uterine bleeding. Diagn Pathol. 2025;20:127. doi:10.1186/s13000-025-01717-z.
10. Endometrial thickness as predictor of endometrial hyperplasia and cancer in perimenopausal uterine bleeding. Bhumibol Adulyadej Hosp Study. 2022;254:1-7. doi:10.1007/s13224-018-1166-9.
11. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;95(7):2204-2208. doi:10.1016/j.fertnstert.2011.03.079.
12. Goldstein RB, et al. Evaluation of the woman with postmenopausal bleeding. J Ultrasound Med. 2001;20(10):1025-1036. doi:10.7863/jum.2001.20.10.1025.
13. Bhatla N, Denny L. FIGO Cancer Report 2018: abnormal uterine bleeding recommendations. Int J Gynaecol Obstet. 2018;143 Suppl 2:2-3. doi:10.1002/ijgo.12666.
14. Wang L, Quan S, Bai E, Yang X. Clinical data of endometrial pathological types in perimenopausal women with abnormal uterine bleeding. Front Oncol. 2024;14:1370681. doi:10.3389/fonc.2024.1370681.
15. Antunes A Jr, Costa-Paiva L, Arthuso M, et al. Endometrial evaluation in perimenopausal abnormal uterine bleeding: systematic review. Eur J Contracept Reprod Health Care. 2022;27(6):504-517. doi:10.1080/13625187.2022.2052639.
16. Jairajpuri ZS, Rana S, Jetley S. Atypical uterine bleeding histopathology audit: 638 cases. Al Ameen J Med Sci. 2013;6(1):21-28. doi:10.21859/ajms2013/6.1.21.
17. Rahiem SW, Salman ST, Mahmod WR. Abnormal uterine bleeding overview. Best Pract Res Clin Obstet Gynaecol. 2016;34:54-65. doi:10.1016/j.bpobgyn.2015.12.004.
18. Wu Y, Sun W, Liu H, Zhang D. Age at menopause and risk of endometrial cancer: meta-analysis. Biomed Res Int. 2019;2019:8584130. doi:10.1155/2019/8584130.
19. Breijer MC, et al. Diagnostic strategies for postmenopausal bleeding. Obstet Gynecol Int. 2010;2010:850812. doi:10.1155/2010/850812.
20. Chodankar R, Critchley HOD. Abnormal uterine bleeding including PALM-COEIN classification. Obstet Gynaecol Reprod Med. 2019;9:98-104. doi:10.1016/j.ogrm.2019.01.009.
21. Singh A, Choudhary A. PALM-COEIN classification in perimenopausal women. J Med Sci Clin Res. 2018;6(6):287-292. doi:10.18535/jmscr/v6i6.49.
22. Valson H, Kulkarni C, Mukerjee S, et al. Role of diagnostic hysteroscopy in abnormal uterine bleeding. Int J Reprod Contracept Obstet Gynecol. 2016;5:609-614. doi:10.18203/2320-1770.ijrcog20160471.
23. Shrestha A, Kayastha B, Makaju R. Diagnostic hysteroscopy in abnormal uterine bleeding: 5-year study. Int J Sci Rep. 2017;3:128-133. doi:10.18203/issn.2454-2156.IntJSciRep20171998.
24. Devi J, Aziz N. Histopathological pattern of endometrium in abnormal uterine bleeding 40-60 years. Int J Med Sci Clin Invent. 2014;1(10):579-585. doi:10.18535/ijmsci/v1i10.579.
25. Azim P, Khattak EG, Khan MM, Sharif N. Evaluation of abnormal uterine bleeding on endometrial biopsies. Isra Med J. 2011;3(3):84-88. doi:10.14302/issn.2320-1770.ijrcog20212977.
26. Spencer CP, Whitehead MI. Endometrial assessment revisited. Br J Obstet Gynaecol. 1999;106(6):623-632. doi:10.1111/j.1471-0528.1999.tb08270.x.
27. Nemer AM, et al. Accuracy of endometrial sampling for diagnosis. Saudi Med J. 2019;40(8):815-819. doi:10.15537/smj.2019.8.24363.
28. National Collaborating Centre for Women’s and Children’s Health. Heavy menstrual bleeding guideline. London: RCOG Press; 2016.
29. Breijer MC, et al. Non-invasive predictors of endometrial pathology in perimenopausal bleeding. Gynecol Obstet Int. 2011;2011:876920. doi:10.1155/2011/876920.
30. Forae GD, Aligbe JU. Histopathological patterns of endometrial lesions in abnormal uterine bleeding. J Basic Clin Reprod Sci. 2013;2(3):10-13. doi:10.4103/0976-7800.104467.